Ceribell - About the company
Ceribell is a public company based in Mountain View (United States), founded in 2014 by Xingjuan Chao, Josef Parvizi and Chris Chafe. It operates as an EEG system for the diagnosis of seizures. Ceribell has raised $188M in funding from investors like The Rise Fund, Longitude Capital and Optima Capital. The company has 263 active competitors, including 86 funded and 9 that have exited. Its top competitors include companies like Insulet, HyperIce and Empatica.
Company Details
EEG system for the diagnosis of seizures. It has developed point-of-care diagnostic devices. The offering includes Ceribell EEG Headband and Ceribell EEG Recorder. The headbands have features for data recording, EEG signal display, brain activity analysis, and EEG monitoring with alerts.
- Website
- ceribell.com
- Email ID
- *****@ceribell.com, *****@ceribell.com
- Phone Number
- +1 **********
- Registered Address
- Mountain View, California
Key Metrics
Founded Year
2014
Location
Mountain View, United States
Stage
Public
Total Funding
$188M in 4 rounds
Latest Funding Round
Investors
Ranked
2nd among 263 active competitors
Annual Revenue
$50M - $100M as on Dec 31, 2025
Employee Count
417 as on Jun 30, 2026
Exit Details
Public
Legal entities associated with Ceribell
Ceribell is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Ceribell, Inc CIN: 32068967580 , United States, Active | Mar 10, 2022 | - | - | - |
CERIBELL INC CIN: 471785452 , United States, Active | Dec 31, 1999 | - | 281 (As on Dec 31, 2024) | - |
Ceribell, Inc. CIN: 1861107 , United States, Active | $50M - $100M (As on Dec 31, 2025) | - | - |
Ceribell's IPO details
Ceribell got listed on Oct 11, 2024.
Click here to take a look at Ceribell's IPO in detail
Sign up to download Ceribell's company profile
Ceribell's funding and investors
Ceribell has raised a total funding of $188M over 4 rounds. Its first funding round was on Sep 25, 2018. Its latest funding round was a Series C round on Sep 22, 2022 for $*****. 1 investor participated in its latest round. Ceribell has 13 institutional investors.
Here is the list of recent funding rounds of Ceribell:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 22, 2022 | 4002911 | Series C | 8132065 | 6981104 | 4925319 | 8928730 |
Apr 22, 2021 | 2635136 | Series C | 8451666 | 6335914 | 8657496 | |
May 01, 2020 | 2291996 | Venture Debt | 8819270 | 5991657 | 6662454 |
View details of Ceribell's funding rounds and investors
Ceribell's founders and board of directors
Founder? Claim ProfileHere are the details of Ceribell's key team members:
- Xingjuan Chao: Co-Founder & CEO of Ceribell.
- Josef Parvizi: Co-Founder of Ceribell. Contact Info: 1 email address
- Chris Chafe: Co-Founder of Ceribell.
View details of Ceribell's Founder profiles and Board Members
Ceribell's employee count trend
Ceribell has 417 employees as of Jun 26. Here is Ceribell's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Ceribell's Competitors and alternates
Top competitors of Ceribell include Insulet, HyperIce and Empatica. Here is the list of Top 10 competitors of Ceribell, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Insulet 2000, Boston (United States), Public | Manufacturer of wearable, tubeless insulin delivery systems for diabetes management | $120M | 77/100 | |
2nd | Ceribell 2014, Mountain View (United States), Public | EEG system for the diagnosis of seizures | $188M | 69/100 | |
3rd | HyperIce 2011, Irvine (United States), Series C | Internet first brand offering smart devices for physical fitness | $52.5M | 68/100 | |
4th | Developer of a wrist band to monitor physiological signals | $30.9M | 66/100 | ||
5th | Cala Health 2013, Stanford (United States), Series D | Developer of a wearable non-invasive neuromodulation device | $257M | 65/100 | |
6th | Cumulus Neuro 2015, Belfast (United Kingdom), Series A | AI and cloud-based brain physiology analysis tool for clinical trials | $19.6M | 61/100 | |
7th | Athelas 2014, Mountain View (United States), Series A | Provider of smart solutions for monitoring heart rate, weight, and blood pressure | $136M | 61/100 | |
8th | Cortical Labs 2019, Melbourne (Australia), Series A | Manufacturer of AI-powered biochips | $11.6M | 59/100 | |
9th | Beacon Biosignals 2019, Boston (United States), Series B | AI-based EEG analysis and diagnosis platform for healthcare providers | $141M | 58/100 | |
10th | BrainScope 2006, Bethesda (United States), Series B | Provider of AI-powered non-invasive medical devices for diagnosing and assessing brain injuries, including concussions and brain bleeds | $62.2M | 58/100 |
Looking for more details on Ceribell's competitors? Click here to see the top ones
Ceribell's Investments and acquisitions
Ceribell has made no investments or acquisitions yet.
Reports related to Ceribell
Here is the latest report on Ceribell's sector:
News related to Ceribell
Media has covered Ceribell for a total of 14 events in the last 1 year, 3 of them have been about company updates and 2 about people movement.
•
•
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Delirium Monitor SystemGlobeNewswire•Aug 03, 2026•Ceribell
•
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O'KeefeGlobeNewswire•Jul 29, 2026•Ceribell
•
•
Ceribell Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire•Feb 25, 2026•Ceribell
•
CeriBell, Inc. $CBLL Shares Acquired by Emerald Mutual Fund Advisers TrustMarketBeat•Jan 24, 2026•Emerald Mutual Funds, Ceribell
•
Ceribell’s LVO Stroke Detection Monitor Wins FDA Breakthrough NodMedical Product Outsourcing•Jan 05, 2026•Ceribell
•
•
Ceribell Receives FDA Clearance for Clarity® AI, Becoming First Point-of-Care EEG for All AgesHIT Consultant•Nov 25, 2025•Ceribell
•
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for NeonatesGlobeNewswire•Nov 24, 2025•Ceribell
Are you a Founder ?
FAQs about Ceribell
Explore our recently published companies
- Shop Wafi - Jeddah based, 2015 founded, Deadpooled company
- Bixabotanical - Mumbai based, 2015 founded, Unfunded company
- Benhurconstruction - Unfunded company
- Saalfo Tech - Mysuru based, 2016 founded, Unfunded company
- Tolia - Thane based, 1979 founded, Unfunded company
- Uvtcpl - Mumbai based, 2023 founded, Unfunded company
